Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Vaccines
Findings from J.J. Hu and co-authors provide new insights into vaccines
October 22nd, 2008
"This study aims to discuss the effect of preventing pathological changes and cognitive degeneration of Tg2576 mice by inoculating the subunit fragment of A beta vaccine. Thirty-two Tg2576 mice were randomly divided into four groups, each having eight mice: Group I, the control group, inoculated with adjuvants; Group II, the A beta(42) group, inoculated with A beta(42) vaccine; Group III, the A beta(1-15) group, inoculated with A beta(1-15) vaccine; and Group IV, the A beta(36-42) group, inoculated with A beta(36-42) vaccine," researchers in Guangzhou, People's Republic of China report. "The titer of the serum antibody against A beta(42) (Group II) was significantly...
Source: Vaccine Weekly (2008-10-22)
|
